Keywords: virexx, presents, encouraging, early, data, hbv, vacc

ViRexx presents encouraging early data on HBV vacc

Article | 01 September 2008

Print This

Canadian therapeutics firm ViRexx Medical Corp has reported encouraging results from the laboratory studies on its lead Chimigen Hepatitis B ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in